Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alisa Jennifer Prager, M.D.

Concepts (136)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glaucoma7202211861.220 Why?
Visual Fields3202110610.890 Why?
Visual Field Tests320214110.770 Why?
Neurocutaneous Syndromes12021530.710 Why?
Arteriovenous Fistula120213190.580 Why?
Eye Diseases220226530.560 Why?
Tomography, Optical Coherence3202229230.540 Why?
Macula Lutea120171770.510 Why?
Fluorescein Angiography1202110620.500 Why?
Retinal Vessels120218540.480 Why?
Glaucoma, Open-Angle120217390.460 Why?
Vision Disorders1202110890.440 Why?
Retinal Ganglion Cells120178100.370 Why?
Visual Acuity2201726760.360 Why?
Disease Management1202125070.350 Why?
Medicare2201867740.320 Why?
Brain Diseases1201515450.250 Why?
Self Report1201637270.230 Why?
Health Care Costs1201632390.210 Why?
Patient Acceptance of Health Care1201632000.200 Why?
Magnetic Resonance Imaging32021364150.200 Why?
Hospitalization22018107070.190 Why?
Medicare Part D220163540.180 Why?
Brain Neoplasms4201590250.180 Why?
beta-Alanine12021820.180 Why?
Ocular Hypertension120222080.170 Why?
Quality of Life42022133670.170 Why?
Blastomycosis12019140.170 Why?
Glioma1201534520.170 Why?
Benzoates120212110.170 Why?
Neoplasm Recurrence, Local2201592780.160 Why?
Fundus Oculi120215570.160 Why?
Dacryocystitis12019680.160 Why?
Scotoma120171280.130 Why?
Health Plan Implementation220163360.130 Why?
Vision, Binocular120172240.130 Why?
Disease Progression32022135110.110 Why?
Hepatocyte Growth Factor120132700.100 Why?
Dacarbazine120155590.100 Why?
Osteopontin120133020.100 Why?
Insulin-Like Growth Factor Binding Protein 3120134150.100 Why?
Health Services Research1201818070.090 Why?
Prostatic Neoplasms12013111010.090 Why?
Drug Costs2201611830.090 Why?
Confidence Intervals1201629280.090 Why?
Cost Savings120159110.090 Why?
Cross-Sectional Studies42018260720.080 Why?
Brain Stem Neoplasms120111890.080 Why?
Area Under Curve1201316360.080 Why?
Antihypertensive Agents2201620190.080 Why?
Metabolic Networks and Pathways120137900.080 Why?
Prescription Drugs120166310.080 Why?
Radiotherapy1201515000.070 Why?
Glioblastoma2201334820.070 Why?
Ophthalmic Solutions220223110.070 Why?
Aged1020181692920.070 Why?
Humans2020227612220.070 Why?
Interferon-alpha120119070.070 Why?
Kidney Transplantation1202242420.070 Why?
Enzyme-Linked Immunosorbent Assay1201338030.070 Why?
Artificial Intelligence1202125760.070 Why?
Molecular Imaging120138180.070 Why?
Female1520213925520.070 Why?
Polyethylene Glycols1201111870.060 Why?
ROC Curve1201335840.060 Why?
Radiation Injuries1201311910.060 Why?
Diagnosis, Differential12021129760.060 Why?
Male1420183607030.060 Why?
Insurance Coverage1201619350.060 Why?
Comorbidity12018105160.060 Why?
Prostate-Specific Antigen1201324650.060 Why?
Diabetes Mellitus1202258420.060 Why?
Neurosurgical Procedures1201520670.060 Why?
Odds Ratio1201696520.060 Why?
Radiosurgery1201313390.060 Why?
Medication Adherence1201521750.060 Why?
Aged, 80 and over32018589520.050 Why?
Databases, Factual1201879650.050 Why?
Longitudinal Studies22016146100.050 Why?
Middle Aged620212208580.050 Why?
Hypertension1202285360.050 Why?
Socioeconomic Factors1201678040.050 Why?
United States42018723410.050 Why?
Sensitivity and Specificity22013146750.050 Why?
Retrospective Studies32022806750.050 Why?
Logistic Models12016132490.050 Why?
Diffusion Magnetic Resonance Imaging1201227870.050 Why?
Antineoplastic Agents22015136320.040 Why?
Neoplasm Staging12013111190.040 Why?
Electromagnetic Fields120002890.040 Why?
Incidence12016213660.040 Why?
Sickness Impact Profile120172990.030 Why?
Prognosis22013296880.030 Why?
Intraocular Pressure1202212940.030 Why?
Prospective Studies22017544370.030 Why?
Antibodies, Monoclonal1201291870.030 Why?
Follow-Up Studies12017391270.030 Why?
Risk Assessment12016240220.030 Why?
Cysts120196800.030 Why?
Financing, Personal120163080.030 Why?
Visual Cortex1200011040.020 Why?
Drug Utilization1201511880.020 Why?
Tissue Distribution1201322630.020 Why?
Graft Rejection1202244810.020 Why?
Necrosis1201316100.020 Why?
Gene Amplification1201310840.020 Why?
Income1201618690.020 Why?
Brain12013270940.020 Why?
Preoperative Care1201322410.010 Why?
Up-Regulation1201341110.010 Why?
Lacrimal Apparatus119662230.010 Why?
Drug Administration Schedule1201148510.010 Why?
Health Expenditures1201623620.010 Why?
Recombinant Proteins1201165040.010 Why?
Disease-Free Survival1201168190.010 Why?
Phosphenes12000410.010 Why?
Combined Modality Therapy1201185190.010 Why?
Sensory Thresholds120003770.010 Why?
Dose-Response Relationship, Radiation120008800.010 Why?
Adolescent32013883000.010 Why?
Reproducibility of Results12013201180.010 Why?
Electric Stimulation1200017360.010 Why?
Electromyography1200013930.010 Why?
Reference Values1200049210.010 Why?
Motor Cortex1200010060.010 Why?
Adult420132211200.010 Why?
Infant22011361700.010 Why?
Child, Preschool22011422250.010 Why?
Transcranial Magnetic Stimulation1200014730.010 Why?
Lung Neoplasms12013133860.000 Why?
Aging1196687020.000 Why?
Young Adult12013592220.000 Why?
Breast Neoplasms12013209820.000 Why?
Child22011801540.000 Why?
Conjunctivitis119661550.000 Why?
Atrophy1196616330.000 Why?
Prager's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (136)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.